Insulet Corporation announced that Bret Christensen, Executive Vice President, Chief Commercial Officer of the Company will be leaving the Company, effective May 5, 2023, in connection with an internal reorganization pursuant to which his position is being eliminated. He will receive standard severance benefits under the Company's Amended and Restated Executive Severance Plan.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
182.1 USD | +2.80% | +3.47% | -15.20% |
May. 30 | Redburn Atlantic Initiates Insulet With Buy Rating, $235 Price Target | MT |
May. 29 | Insulet Insider Sold Shares Worth $596,970, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.20% | 12.41B | |
-6.29% | 178B | |
-0.04% | 107B | |
-1.33% | 67.04B | |
-6.40% | 47.23B | |
+10.88% | 44.62B | |
+9.25% | 42.5B | |
+15.26% | 29.99B | |
+15.97% | 25.22B | |
-5.07% | 24.14B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Bret Christensen, Executive Vice President, Chief Commercial Officer Will Be Leaving Insulet Corporation